This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Colon Cancer  • Surgical Oncology  • Prognosis/ Outcomes  • Hepatobiliary Surgery  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Emerging as a Reliable Preoperative Prognostic Index in Hepatectomy for Colorectal Metastases

Chris D. Mann, BSc; Matthew S. Metcalfe, MBBChir; Lisa N. Leopardi, BEng(Biomed)Hon; Guy J. Maddern, MD

Arch Surg. 2004;139:1168-1172.

Hypothesis  The purpose of this study was to examine the validity of the clinical risk score (CRS), a prognostic tool developed by Fong et al, when translated to another center.

Design  This study assesses 5 independent preoperative prognostic criteria, nodal status of the primary lesion, disease-free interval, number of hepatic metastases, size of the largest metastasis, and preoperative carcinoembryonic antigen level, to determine a preoperative CRS for each patient included in the study.

Setting  The hepatobiliary unit of The Queen Elizabeth Hospital, Adelaide, South Australia.

Patients  Medical records of patients admitted to The Queen Elizabeth Hospital undergoing potentially curative hepatic resection for colorectal metastases during the period of July 1993 to April 2003 were included in the study.

Main Outcome Measure  The primary outcome measure of the study was survival. The calculated CRS was analyzed with respect to patient postoperativesurvival.

Results  During the 10-year period, 77 patients underwent hepatic resection. Overall survival rates for 1, 3, and 5 years were found to be 80.9%, 57.5%, and 42.3%, respectively. One- and 5-year survival rates for CRSs of 0 and 1 were found to be 93.8% and 72.5%, respectively; for scores of 2 and 3, 76.6% and 31.2%, respectively;and for scores of 4 and 5, 75% and 0%, respectively. No patient with a CRS greater than 3 survived more than2 years.

Conclusion  This study validates the CRS, finding it to be highly predictive of patient outcome and survival.

Author Affiliations: University of Adelaide, Department of Surgery, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perioperative Carcinoembryonic Antigen Measurements to Predict Curability After Liver Resection for Colorectal Metastases: A Prospective Study
Oussoultzoglou et al.
Arch Surg 2008;143:1150-1158.
ABSTRACT | FULL TEXT  

Simplified Staging System for Predicting the Prognosis of Patients With Resectable Liver Metastasis: Development and Validation
Minagawa et al.
Arch Surg 2007;142:269-276.
ABSTRACT | FULL TEXT  

In Reply:
Liersch et al.
JCO 2006;24:2680-2681.
FULL TEXT